AKCEA THERAPEUTICS INC's ticker is and the CUSIP is 00972L907. A total of 4 filers reported holding AKCEA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $5,000 | -37.5% | 3 | -50.0% | 0.00% | – |
Q2 2020 | $8,000 | -76.5% | 6 | -75.0% | 0.00% | – |
Q1 2020 | $34,000 | +25.9% | 24 | +50.0% | 0.00% | – |
Q4 2019 | $27,000 | -51.8% | 16 | -56.8% | 0.00% | – |
Q3 2019 | $56,000 | -50.0% | 37 | -22.9% | 0.00% | – |
Q2 2019 | $112,000 | +4.7% | 48 | +26.3% | 0.00% | – |
Q1 2019 | $107,000 | +174.4% | 38 | +192.3% | 0.00% | – |
Q4 2018 | $39,000 | -85.3% | 13 | -82.9% | 0.00% | -100.0% |
Q3 2018 | $266,000 | – | 76 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 24,100 | $726,000 | 0.01% |
JPMORGAN CHASE & CO | 193,500 | $5,832,000 | 0.00% |
SIMPLEX TRADING, LLC | 13 | $39,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |